Preparation of 213bi-dota-biotin in high specific activity for pretargeted alpha radiotherapy of cancer
The alpha emitter, Bismuth‐213, (213Bi) T1/2 = 45 min, obtained from an 225Ac generator, was chelated to DOTA‐biotin in high radiochemical yield and specific activity. The radiolabeled product showed good radiochemical stability and was used in preclinical therapy studies using a pretargeting format...
Gespeichert in:
Veröffentlicht in: | Journal of labelled compounds & radiopharmaceuticals 2001-05, Vol.44 (S1), p.S726-S728 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The alpha emitter, Bismuth‐213, (213Bi) T1/2 = 45 min, obtained from an 225Ac generator, was chelated to DOTA‐biotin in high radiochemical yield and specific activity. The radiolabeled product showed good radiochemical stability and was used in preclinical therapy studies using a pretargeting format. |
---|---|
ISSN: | 0362-4803 1099-1344 |
DOI: | 10.1002/jlcr.25804401256 |